These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33332701)

  • 21. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
    Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The result patterns of ML Flow and ELISA (PGL-I) serologic tests in leprosy-endemic and non-endemic areas.
    Silva RC; Lyon S; Araos R; Lyon AC; Grossi MA; Lyon SH; Penido RA; Bührer-Sékula S; Antunes CM
    Rev Soc Bras Med Trop; 2008; 41 Suppl 2():19-22. PubMed ID: 19618070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical synthesis and serology of disaccharides and trisaccharides of phenolic glycolipid antigens from the leprosy bacillus and preparation of a disaccharide protein conjugate for serodiagnosis of leprosy.
    Fujiwara T; Hunter SW; Cho SN; Aspinall GO; Brennan PJ
    Infect Immun; 1984 Jan; 43(1):245-52. PubMed ID: 6360898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy.
    Cho SN; Cellona RV; Villahermosa LG; Fajardo TT; Balagon MV; Abalos RM; Tan EV; Walsh GP; Kim JD; Brennan PJ
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):138-42. PubMed ID: 11139208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Latent leprosy infection identified by dual RLEP and anti-PGL-I positivity: Implications for new control strategies.
    da Silva MB; Li W; Bouth RC; Gobbo AR; Messias ACC; Moraes TMP; Jorge EVO; Barreto JG; Filho FB; Conde GAB; Frade MAC; Salgado CG; Spencer JS
    PLoS One; 2021; 16(5):e0251631. PubMed ID: 33984058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of phenolic glycolipid-I (Mycobacterium leprae) and sulfolipid-I (M. tuberculosis) by serum from Mexican patients with leprosy or tuberculosis.
    Rojas-Espinosa O; Luna-Herrera J; Arce-Paredes P
    Int J Tuberc Lung Dis; 1999 Dec; 3(12):1106-12. PubMed ID: 10599015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes.
    Schlesinger LS; Horwitz MA
    Infect Immun; 1994 Jan; 62(1):280-9. PubMed ID: 8262640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ELISA detection of IgM antibodies against phenolic glycolipid-I in the management of leprosy: a comparison between laboratories.
    Meeker HC; Levis WR; Sersen E; Schuller-Levis G; Brennan PJ; Buchanan TM
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):530-9. PubMed ID: 3546543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of anti-phenolic glycolipid-I IgM levels using an ELISA for detection of M. leprae infection in populations of the South Pacific Islands.
    Cartel JL; Chanteau S; Boutin JP; Plichart R; Richez P; Roux JF; Grosset JH
    Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):512-7. PubMed ID: 2205686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Field-friendly anti-PGL-I serosurvey in children to monitor
    Pierneef L; Malaviya P; van Hooij A; Sundar S; Singh AK; Kumar R; de Jong D; Meuldijk M; Kumar A; Zhou Z; Cloots K; Corstjens P; Hasker E; Geluk A
    Front Med (Lausanne); 2023; 10():1260375. PubMed ID: 37828950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.
    Reece ST; Ireton G; Mohamath R; Guderian J; Goto W; Gelber R; Groathouse N; Spencer J; Brennan P; Reed SG
    Clin Vaccine Immunol; 2006 Mar; 13(3):333-40. PubMed ID: 16522774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gelatin particle agglutination assay to detect anti-PGL-I antibodies in leprosy patients and in household contacts: a preliminary study.
    Mahajan P; Jogaikar DG; Jadhav VH; Mehta JM
    Indian J Lepr; 1992; 64(4):461-7. PubMed ID: 1308520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of phenolic glycolipid 1 for serodiagnosis of leprosy in a high prevalence village in Papua New Guinea.
    Baumgart K; Britton W; Basten A; Bagshawe A
    Trans R Soc Trop Med Hyg; 1987; 81(6):1030-2. PubMed ID: 3332501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.
    Stefani MM; Martelli CM; Morais-Neto OL; Martelli P; Costa MB; de Andrade AL
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):356-64. PubMed ID: 9934362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy.
    Cho SN; Yanagihara DL; Hunter SW; Gelber RH; Brennan PJ
    Infect Immun; 1983 Sep; 41(3):1077-83. PubMed ID: 6193065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.
    Hungria EM; Oliveira RM; Souza AL; Costa MB; Souza VN; Silva EA; Moreno FR; Nogueira ME; Costa MR; Silva SM; Bührer-Sékula S; Reed SG; Duthie MS; Stefani MM
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():104-11. PubMed ID: 23283461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Field-friendly serological tests for determination of M. leprae-specific antibodies.
    van Hooij A; Tjon Kon Fat EM; van den Eeden SJF; Wilson L; Batista da Silva M; Salgado CG; Spencer JS; Corstjens PLAM; Geluk A
    Sci Rep; 2017 Aug; 7(1):8868. PubMed ID: 28827673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae.
    Bührer SS; Smits HL; Gussenhoven GC; van Ingen CW; Klatser PR
    Am J Trop Med Hyg; 1998 Feb; 58(2):133-6. PubMed ID: 9502593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.
    Menzel S; Harboe M; Bergsvik H; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.
    Levis WR; Meeker HC; Schuller-Levis GB; Gillis TP; Marino LJ; Zabriskie J
    J Clin Microbiol; 1986 Dec; 24(6):917-21. PubMed ID: 3537003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.